Contrast medium-induced nephropathy: Strategies for prevention

Pharmacotherapy

Volumn 28, Issue 9, 2008, Pages 1140-1150

  Massicotte, Anne ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

CIN; Contrast medium induced nephropathy; N acetylcysteine; Renal failure; Sodium bicarbonate; Sodium chloride

Indexed keywords

ACETYLCYSTEINE; ASCORBIC ACID; BICARBONATE; CONTRAST MEDIUM; INFUSION FLUID; IOPAMIDOL; SODIUM CHLORIDE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOTOXICITY; DIABETIC NEPHROPATHY; DIZZINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; FLUSHING; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TUBULE CELL; OUTCOME ASSESSMENT; PHARMACIST; PRURITUS; RASH; REVIEW; RISK FACTOR; SIDE EFFECT;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; PHARMACISTS; RISK FACTORS; SODIUM BICARBONATE;

EID: 51849099423     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.9.1140     Document Type: Review

References (40)

1. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006;113:1799-806.
2. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-86.
3. Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int 2006;69:S11-15.
4. McElhiney LF. N-acetylcysteine used to decrease the incidence of contrast-induced nephropathy following radiographic procedures: a literature review. Int J Pharm Compound 2005;9:99-103.
5. Pannu N, Tonelli M. Strategies to reduce the risk of contrast nephropathy: an evidence-based approach. Curr Opin Nephrol Hypertens 2006;15:285-90.
6. Briguori C, Tavano D, Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis 2003;45:493-503.
7. Andrew E, Berg KJ. Nephrotoxic effects of x-ray contrast media. J Tox Clin Tox 2004;42:325-32.
8. Canadian Association of Radiologists. Consensus guidelines for the prevention of CIN. Available from http://www.car.ca/fr/about/standards/library/ Nephropathy.pdf. Accessed October 19, 2007.
9. Erley C. Concomitant drugs with exposure to contrast media. Kidney Int 2006;69:520-4.
10. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int 2006;69:S16-19.
11. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy. Arch Intern Med 2002;162:329-36.
12. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 2004;291:2328-34.
13. Burgess WP, Merten GJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate [letter]. JAMA 2004;292:1428-9.
14. Repchinsky C, ed. Mucomyst monograph. In: Compendium of pharmaceuticals and specialties. Ottawa, Canada: Canadian Pharmacists Association; 2007:1508-9.
15. Shalansky SJ, Vu T, Pate GE, Levin A, Humphries KH, Webb JG. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? Pharmacotherapy 2005;25:1095-103.
16. Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
17. Birck R, Krzossok S, Markowetz F, Schnulle P, Van der Woude J, Braun C. Acetylcysteine for prevention of contrast-nephropathy: a meta-analysis. Lancet 2003;362:598-603.
18. Isenbarger DW, Kent SM, O'Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 2003;92:1454-8.
19. Misra D, Leibowitz K, Gowda RM, Shapiro M, Khan IA. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis. Clin Cardiol 2004;27:607-10.
20. Alonsa A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 2004;43:1-9.
21. Guru V, Fremes SE. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol 2004;62:77-83.
22. Bagshaw SM, Ghali WA. Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis. BMC Med 2004;2:38-49.
23. Liu R, Nair D, Ix J, Moore DH. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med 2005;20:193-200.
24. Duong MH, Mackenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv 2005;64:471-9.
25. Zagler A, Azadpour M, Mercado C, Hennekens H. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 2006;151:140-5.
26. Nallamothu BK, Shojania KG, Saint S, et al. Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. Am J Med 2004;117:938-47.
27. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 2004;65:1366-74.
28. Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. J Am Soc Nephrol 2004;15:761-9.
29. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast agent-associated nephropathy. J Am Coll Cardiol 2002;40:298-303.
30. Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent-associated nephrotoxicity. Eur Heart J 2004;25:206-11.
31. Baker CS, Wragg A, Kumar S, De Palma R, Baker LRI, Knight CJ. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 2003;41:2114-18.
32. Webb JG, Pate GE, Humphries KH, et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 2004;148:422-9.
33. Rashid ST, Salman M, Myint F, et al. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine. J Vasc Surg 2004;40:1136-41.
34. Carbonell N, Blasco M, Sanjuan R, et al. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy : a randomized trial. Int J Cardiol 2007;115:57-62.
35. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82.
36. American College of Radiology. ACR manual on contrast media, contrast nephrotoxicity. Available from http://www.acr.org/ SecondaryMainMenuCategories/quality_safety/contrast_manual/ ContrastNephrotoxicityDoc10.aspx. Accessed November 16, 2007.
37. Palacioz K. Acetylcysteine to prevent contrast media-induced renal damage. In: Jellin JM, ed. Pharmacist's letter, detail-document 170311. Stockton, CA; Therapeutic Research Center, 2001.
38. Ozcan EE, Guneri S, Akdeniz B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy: a comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures - a single-centre prospective controlled trial. Am Heart J 2007;154:539-44.
39. Briguori C, Airoldi F, D'Andrea D, et al. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007;115:1211-17.
40. Recio-Mayoral A, Chaparro M, Prado B, et al. The renoprotective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO study. J Am Coll Cardiol 2007;49:1283-8.